Company Quick10K Filing
RXI Pharmaceuticals
S-1 2020-07-09 Public Filing
10-Q 2020-06-30 Filed 2020-08-12
S-1 2020-05-12 Public Filing
10-Q 2020-03-31 Filed 2020-05-12
S-1 2019-10-01 Public Filing
10-Q 2019-09-30 Filed 2019-11-12
S-1 2019-08-30 Public Filing
10-Q 2019-06-30 Filed 2019-08-12
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-03-27
10-Q 2018-09-30 Filed 2018-11-14
S-1 2018-08-31 Public Filing
10-Q 2018-06-30 Filed 2018-08-14
S-1 2018-05-09 Public Filing
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-26
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-30
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-11
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-03-30
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-28
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-29
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-14
8-K 2020-08-12 Earnings, Exhibits
8-K 2020-05-12
8-K 2019-12-16
8-K 2019-11-19
8-K 2019-11-12
8-K 2019-11-12
8-K 2019-10-24
8-K 2019-08-12
8-K 2019-08-07
8-K 2019-05-14
8-K 2019-03-27
8-K 2019-02-13
8-K 2019-01-22
8-K 2018-12-19
8-K 2018-11-14
8-K 2018-11-14
8-K 2018-11-13
8-K 2018-10-01
8-K 2018-09-26
8-K 2018-08-31
8-K 2018-08-17
8-K 2018-08-14
8-K 2018-06-05
8-K 2018-05-31
8-K 2018-05-10
8-K 2018-04-09
8-K 2018-03-29
8-K 2018-03-27
8-K 2018-03-26
8-K 2018-03-20
8-K 2018-01-23
8-K 2018-01-04

RXI Pharmaceuticals Financials

RXII Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Quest Patent Research (QPRC) 8 31% -46.2 -31% 4 10 2 1 -1 -0 9
Lithium (LTUM) 8 32.1 28% 1 0 0 0 0 0 7
Voltari (VLTC) 8 0% -82.9 -9% 22 28 2 0 -2 -0 30
Capstone Companies (CAPC) 8 22% 109.3 0% 7 1 12 3 0 0 5
Fision (FSSN) 7 85% -1.7 -314% 2 5 0 0 -5 -5 8
ForeverGreen (FVRG) 7 77% 43.6 -50% 3 12 12 9 -2 0 8
Castle AM (CTAM) 7 0% 45.0 -8% 347 382 434 0 -29 6 262
Sonic Foundry (SOFO) 7 73% -4.2 -24% 15 21 35 26 -4 -2 9
RXI Pharmaceuticals (RXII) 7 0% -0.5 -194% 4 2 0 0 -7 -7 4
Ethema Health (GRST) 7 0% -1.2 -32% 23 33 1 0 -8 -6 7
Vivos (RDGL) 7 0% -7.6 -561% 0 1 0 0 -1 -1 7
Mikros Systems (MKRS) 7 61% -32.0 -4% 3 1 5 3 -0 -0 5
Pressure Biosciences (PBIO) 7 41% -1.9 -331% 2 12 2 1 -8 -4 7
MGT Capital Investments (MGTI) 7 -31% -0.6 -144% 5 2 0 -0 -8 -8 5
International Stem Cell (ISCO) 7 62% -5.0 -19% 8 5 7 4 -2 -1 7
Star Gold (SRGZ) 7 -29.3 -31% 1 0 0 0 -0 -0 7
Westmoreland Coal (WLB) 7 22% -73.7 -15% 1,468 2,191 1,265 282 -219 -13 973
Vaso (VASO) 7 54% -5.8 -7% 46 43 52 28 -3 -1 6
Scientific Industries (SCND) 7 43% 6.9 5% 9 3 10 4 0 1 6
Vitality Biopharma (VBIO) 7 0% -0.2 -324% 4 2 0 0 -14 -14 3

Balance Sheet ($MM)2012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash08652097119125876454421310854353
Accounts Receivable
Inventory
PP&E000000000000000000000000000
Assets187620181615121311971513118751311864364
Accounts Payable100000000000010100011111110
Long-Term Debt
Liabilities311222126666522212232232332
Stockholders' Equity-2-3-4-687756753313119753118632132
Income Statement ($MM)2012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue0000000000000
Cost of Revenue
Gross Profit
R&D17111414111112212211111111111
SG&A111111111111111111111111111
Tax00
Net Income-2-8-2-12,074-14-2-2-3-2-2-2-2-3-2-2-3-2-2-2-2-5-3-2-2-2-2-1
Cash Flow ($MM)2012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-1-1-1-1-1-2-2-1-2-2-2-2-2-2-2-3-2-2-1-3-2-2-2-2-2
Cash Investing-0-00-060-55-0-80222-020-0-000
Cash Financing19-0-0160-0000-009001001-0